Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
Taiwan - Delayed Quote TWD

PharmaEssentia Corporation (6446.TW)

Compare
536.00
+6.00
+(1.13%)
At close: April 2 at 1:30:02 PM GMT+8
Currency in TWD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
9,734,814
9,734,814
5,105,615
2,882,042
656,506
Cost of Revenue
1,177,225
1,177,225
610,544
812,288
378,856
Gross Profit
8,557,589
8,557,589
4,495,071
2,069,754
277,650
Operating Expense
6,821,512
6,821,512
6,408,465
4,097,946
3,100,058
Operating Income
1,736,077
1,736,077
-1,913,394
-2,028,192
-2,822,408
Net Non Operating Interest Income Expense
895,263
895,263
538,436
21,913
-5,339
Pretax Income
2,994,652
2,994,652
-986,934
-1,841,871
-2,810,988
Tax Provision
29,149
29,149
-363,099
-467,061
--
Net Income Common Stockholders
2,965,503
2,965,503
-623,835
-1,374,810
-2,810,988
Diluted NI Available to Com Stockholders
2,965,503
2,965,503
-623,835
-1,374,810
-2,810,988
Basic EPS
8.96
--
-1.93
-4.84
-10.80
Diluted EPS
8.88
--
-1.93
-4.84
-10.80
Basic Average Shares
331,100
--
322,479
284,207
260,166
Diluted Average Shares
334,052
--
322,479
284,207
260,166
Total Expenses
7,998,737
7,998,737
7,019,009
4,910,234
3,478,914
Net Income from Continuing & Discontinued Operation
2,965,503
2,965,503
-623,835
-1,374,810
-2,810,988
Normalized Income
2,965,503
2,965,503
-623,835
-1,374,810
-2,810,988
Interest Income
917,455
917,455
585,127
40,441
4,631
Interest Expense
22,192
22,192
46,691
18,528
9,970
Net Interest Income
895,263
895,263
538,436
21,913
-5,339
EBIT
3,016,844
3,016,844
-940,243
-1,823,343
-2,801,018
EBITDA
3,384,556
3,384,556
-671,486
-1,595,424
-2,573,937
Reconciled Cost of Revenue
1,177,225
1,177,225
610,544
812,288
378,856
Reconciled Depreciation
367,712
367,712
268,757
227,919
227,081
Net Income from Continuing Operation Net Minority Interest
2,965,503
2,965,503
-623,835
-1,374,810
-2,810,988
Normalized EBITDA
3,384,556
3,384,556
-671,486
-1,595,424
-2,573,937
Tax Rate for Calcs
0
0
0
0
--
12/31/2021 - 3/11/2014

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

6472.TW Bora Pharmaceuticals Co., LTD.
692.00
-0.86%
 
1795.TW Lotus Pharmaceutical Co., Ltd.
232.00
-0.85%
 
4746.TW Formosa Laboratories, Inc.
67.80
+2.73%
 
4123.TWO Center Laboratories, Inc.
38.05
+0.26%
 
3705.TW YungShin Global Holding Corporation
58.80
+1.03%
 
4114.TWO Synmosa Biopharma Corporation
33.95
+0.15%
 
4105.TWO TTY Biopharm Company Limited
75.70
+2.16%
 
6785.TWO Alar Pharmaceuticals Inc.
133.00
+1.53%
 
1707.TW Grape King Bio Ltd
142.00
0.00%
 
6576.TWO Foresee Pharmaceuticals Co., Ltd.
79.10
0.00%